Volume | 550 |
|
|||||
News | - |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Fresh2 Group Ltd | FRES | NASDAQ | Depository Receipt |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.3401 |
Trades | Shares Traded | Average Volume |
---|---|---|
16 | 550 | - |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
06:20:53 | formt | 100 | 0.329 | USD |
Fresh2 Group Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
0 | 0.00 | - | 12.04M | -101.89M | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Fresh2
Date | Time | Source | Heading |
---|---|---|---|
5/23/2024 | 16:20 | Edgar (US Regulatory) | Form 8-K - Current report |
5/23/2024 | 16:18 | GlobeNewswire Inc. | Fresh2 Group Ltd. Announces Receipt of a Delinquency.. |
4/22/2024 | 07:00 | GlobeNewswire Inc. | Fresh2 Group Ltd. Announces Receipt of a Delinquency.. |
2/20/2024 | 08:00 | GlobeNewswire Inc. | Fresh2 Launches TikTok Video E-commerce Venture, Bridging.. |
2/16/2024 | 15:36 | Edgar (US Regulatory) | Form 8-K - Current report |
2/01/2024 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
1/31/2024 | 15:38 | GlobeNewswire Inc. | Fresh2 Group Ltd. Announces Receipt of a Bid Deficiency.. |
1/29/2024 | 16:29 | Edgar (US Regulatory) | Form 8-K - Current report |
1/29/2024 | 16:29 | Edgar (US Regulatory) | Form 8-K - Current report |
1/26/2024 | 15:31 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
1/09/2024 | 15:24 | Edgar (US Regulatory) | Form 20-F/A - Annual and transition report of foreign.. |
1/04/2024 | 08:00 | PR Newswire (US) | Fresh2 Group Ltd. Announces Acquisition of Cross-Border Food.. |
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
FRES Historical
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
AnPac Bio-Medical Science Co Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis and recurrence. |